Gene expression: Page 3

Severe COVID-19 linked in study with genetic signs of brain aging
By LabPulse.com staff writers
Scientists used RNA sequencing to assess changes in gene expression profiles in the brains of COVID-19 patients and compared them to changes observed in the brains of uninfected individuals, including older people.
December 7, 2022
Covid Brain Visual Social
Exact Sciences shares rise with 15% growth in Q3 revenues
By Leo O'Connor
Screening segment revenue, including sales for the Cologuard colon cancer molecular test, was $360.8 million, an increase of 29% year-over-year.
November 4, 2022
Colon Intestine Social
At AMP 2022, Immunexpress launches rapid test for sepsis requiring two minutes hands-on time
By Leo O'Connor
The firm obtained FDA 510(k) clearance for its SeptiCyte Rapid test last year. The test runs on the sample-to-answer Biocartis Idylla molecular testing platform.
November 5, 2022
Img Updated
Castle Biosciences reports results for gene expression tests in melanoma study
By LabPulse.com staff writers
Castle Biosciences described studies evaluating its DecisionDx-Melanoma and DecisionDx-UM gene expression profile tests, conducted in collaboration with the National Cancer Institute.
October 27, 2022
Melanoma
PacBio, Twist Bioscience collaborate to launch long-read gene panels for research
By LabPulse.com staff writers
One panel covers nearly 400 challenging genes associated with spinal muscular atrophy, Alzheimer’s, cardiovascular disease, and other diseases.
October 19, 2022
Dna Genome Gene Targeted
Biofidelity developing assay for single-molecule detection of multiple gene fusions
By LabPulse.com staff writers
The firm said its assay analyzes DNA and RNA concurrently from a single patient sample and can return results within two days.
October 18, 2022
Lung Cancer2 Social
Castle Biosciences presents case study on performance of gene expression profile test at CAP22
By LabPulse.com staff writers
The test supported the need to perform local excision on a difficult-to-diagnose melanocytic lesion.
October 11, 2022
Melanoma
PerkinElmer highlights cell and gene therapy at SLAS 2022
By LabPulse.com staff writers
The company is showcasing work it is doing with new partners Horizon Discovery, BioLegend, Nexcelom Bioscience, and Omni International, which ranges from automation, liquid handling, high-content screening, cell painting, multimode detection, gene editing tools, and functional genomic screening services and libraries. The company is also touting its work in cell counting, antibodies for flow cytometry, recombinant proteins, and no-wash immunoassay kits, PerkinElmer said.
February 6, 2022
2020 05 07 21 56 6186 Perkin Elmer Headquarters 400
Video from ASH 2021: Gene therapy 2.0: The latest in gene editing
The presentations compared new approaches to gene editing with more established approaches in the field, according to Leah Cepko, a science advisor with Science and Medicine Group, parent company of LabPulse.com. Click on the video below to learn more.
December 13, 2021
2021 12 10 19 28 1244 Ash 2021 Sign 400
Mission Bio weaves Tapestri into cell and gene therapy
Tapestri is Mission Bio's proprietary single-cell genotyping and phenotyping platform, which captures single cells for downstream single-cell DNA sequencing -- this can be combined with simultaneous immunophenotyping. Applications for Tapestri in the cell and gene therapy field can include product characterization, on- and off-target editing, editing co-occurrence, and copy-number analysis, among other uses.
November 3, 2021
2021 11 05 21 07 3284 2021 11 04 Mission Bio Thumbnail
Sherlock gets $7.5M to create COVID-19 diagnostics
By LabPulse.com staff writers
The nondilutive grant funding will help Sherlock further advance its CRISPR gene-editing technology platform, which it used to create its Sherlock CRISPR SARS-CoV-2 detection kit. The funding will also support the development of the company's Inspectr platform, which powers its COVID-19 diagnostic.
May 20, 2020
2020 02 20 18 12 3118 Money Bills 400
CRISPR proteins lead to novel POC diagnostics
By Joseph Constance
CRISPR (clustered regularly interspaced short palindromic repeats) represents a bacterial immune system that contains a programmable protein able to cut DNA or RNA. With this technology, genes can be edited and modified in living cells and organisms. While much effort has gone into developing CRISPR to treat disease, CRISPR is also a platform for diagnostics.
February 9, 2020
2019 05 22 19 44 5254 Dna Red Laser 400
Previous Page
Page 3 of 4
Next Page